Trial: 202108029

A phase ll, open-label, multicenter study evaluating the safety and efficacy of neoadjuvant and adjuvant tiragolumab plus atezolizumab, with or without platinum-based chemotherapy, in patients with previously untreated locally advanced resectable stage ll, lllA, or select lllB non-small cell lung cancer